Vanderbilt Ingram Cancer Center

Breast cancer study explores therapy to slow recurrence

Many patients with triple-negative breast cancer (TNBC) have recurrence of their disease after an initial response to chemotherapy because the cancer cells have become resistant to treatment. TNBC has a lower survival rate because of this pattern of resistance and there are no targeted agents to treat this form of breast cancer.

Patient’s cancer journey inspires fund for research

There’s a long list of Vanderbilt faculty and staff who made an impact on Terri and Steve Voland when Steve was treated at Vanderbilt-Ingram Cancer Center for a rare type of cancer in his neck and spine.

Stomach

Study offers insights into gastric cancer prevention

Gastric cancer is the second leading cause of cancer death worldwide, with a particular burden in Latin America and eastern Asia.

Vaccination key to preventing HPV-related cancers

Vaccinating young males and females against several types of human papillomavirus (HPV) could dramatically reduce the incidence of HPV-related cancers worldwide, according to Douglas Lowy, M.D., deputy director of the National Cancer Institute.

New fluorescing agent shines light on bladder cancer cells

Two urologic surgeons at Vanderbilt-Ingram Cancer Center are among a leading group of cancer physicians using an innovative new imaging agent and blue light system to “light up” cancerous cells inside the bladder.

Factor CITED in pediatric liver cancer

Vanderbilt researchers report that they have found a factor involved in the persistence of embryonic cells implicated in childhood liver cancer.

1 49 50 51 52 53 58